PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 158 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $113,000 | -54.8% | 21,500 | -50.0% | 0.00% | 0.0% |
| Q2 2019 | $250,000 | +20.2% | 43,000 | +62.3% | 0.00% | 0.0% |
| Q1 2019 | $208,000 | +147.6% | 26,500 | +23.3% | 0.00% | 0.0% |
| Q4 2018 | $84,000 | -59.6% | 21,500 | -18.9% | 0.00% | 0.0% |
| Q3 2018 | $208,000 | -5.0% | 26,500 | -1.9% | 0.00% | 0.0% |
| Q2 2018 | $219,000 | +231.8% | 27,000 | +200.0% | 0.00% | – |
| Q1 2018 | $66,000 | +26.9% | 9,000 | 0.0% | 0.00% | – |
| Q4 2017 | $52,000 | 0.0% | 9,000 | 0.0% | 0.00% | – |
| Q3 2017 | $52,000 | -17.5% | 9,000 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $63,000 | -26.7% | 9,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $86,000 | -4.4% | 9,000 | -10.0% | 0.00% | 0.0% |
| Q4 2016 | $90,000 | -38.8% | 10,000 | -71.0% | 0.00% | -50.0% |
| Q1 2016 | $147,000 | -33.5% | 34,500 | -2.8% | 0.00% | -33.3% |
| Q4 2015 | $221,000 | +10.5% | 35,500 | +1.4% | 0.00% | +50.0% |
| Q3 2015 | $200,000 | -21.3% | 35,000 | +2.9% | 0.00% | -33.3% |
| Q2 2015 | $254,000 | +30.9% | 34,000 | +4.6% | 0.00% | +50.0% |
| Q1 2015 | $194,000 | -28.4% | 32,500 | -13.3% | 0.00% | -33.3% |
| Q4 2014 | $271,000 | +29.0% | 37,500 | -7.4% | 0.00% | 0.0% |
| Q3 2014 | $210,000 | +22.1% | 40,500 | +1.2% | 0.00% | 0.0% |
| Q2 2014 | $172,000 | +18.6% | 40,000 | +12.7% | 0.00% | +50.0% |
| Q1 2014 | $145,000 | -23.3% | 35,500 | +2.9% | 0.00% | -33.3% |
| Q4 2013 | $189,000 | +11.8% | 34,500 | +3.0% | 0.00% | 0.0% |
| Q3 2013 | $169,000 | – | 33,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|